Camp4 Therapeutics (CAMP) Total Current Liabilities (2023 - 2026)
Camp4 Therapeutics recorded quarterly Total Current Liabilities of $16.6 million in Q1 2026, up 7.15% quarter-over-quarter from $15.5 million in Q4 2025, and up 158.1% year-over-year from $6.4 million in Q1 2025.
Camp4 Therapeutics' Total Current Liabilities history runs 4 years deep, the most recent figure standing at $16.6 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 158.1% year-over-year to $16.6 million; the TTM figure through Mar 2026 stood at $16.6 million (up 158.1% YoY), while the FY2025 annual figure was $15.5 million, up 61.64% from the prior year.
- Total Current Liabilities came in at $16.6 million for Q1 2026 at Camp4 Therapeutics, up from $15.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $16.6 million in Q1 2026 to a low of $6.4 million in Q1 2025.
- A 4-year average of $10.4 million and a median of $8.8 million in 2024 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities tumbled 33.19% in 2025 and jumped 158.1% in 2026, its largest moves.
- Camp4 Therapeutics' Total Current Liabilities stood at $7.8 million in 2023, then gained by 22.94% to $9.6 million in 2024, then soared by 61.64% to $15.5 million in 2025, then gained by 7.15% to $16.6 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $16.6 million, $15.5 million, and $7.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.11 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | 16.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.62 Mn |
| Dec 31, 2025 | 15.51 Mn |
| Sep 30, 2025 | 7.90 Mn |
| Jun 30, 2025 | 7.34 Mn |
| Mar 31, 2025 | 6.44 Mn |
| Dec 31, 2024 | 9.60 Mn |
| Sep 30, 2024 | 11.83 Mn |
| Dec 31, 2023 | 7.81 Mn |